Annis Gardner Whiting Capital Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Buy |
10,654
+3,125
| +42% | +$86.2K | 0.1% | 173 |
|
|
2025
Q1 | $213K | Buy |
7,529
+2,088
| +38% | +$59.2K | 0.09% | 181 |
|
|
2024
Q4 | $226K | Buy |
5,441
+725
| +15% | +$30.1K | 0.06% | 196 |
|
|
2024
Q3 | $315K | Buy |
4,716
+293
| +7% | +$19.6K | 0.09% | 177 |
|
|
2024
Q2 | $525K | Buy |
4,423
+4,420
| +147,333% | +$525K | 0.15% | 123 |
|
|
2024
Q1 | $320 | Buy |
+3
| New | +$320 | ﹤0.01% | 920 |
|
|
2023
Q4 | – | Sell |
-24
| Closed | -$2.48K | – | 712 |
|
|
2023
Q3 | $2.48K | Buy |
+24
| New | +$2.48K | ﹤0.01% | 597 |
|